Evidence map›Paper›PMID 29542036›Full record

ArticleInternational journal of clinical pharmacy2018

Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy.

Geoffrey C Wall, Matthew J Taylor, Hayden L Smith

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. MRGPRX2 and Adverse Drug Reactions.Frontiers in immunology · 2021
    Review
  5. Review
  6. Quinolone Allergy.Pharmacy (Basel, Switzerland) · 2019
    Review
  7. Overview of this issue: pharmacovigilance, what is new?International journal of clinical pharmacy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Geoffrey C WallCollege of Pharmacy and Health Sciences, Drake University, 2507 University Ave., Des Moines, IA, 50310, USA. geoff.wall@drake.edu.
Matthew J TaylorPGY-2 Internal Medicine Resident, Iowa Methodist Medical Center, Des Moines, IA, USA.
Hayden L SmithIowa Methodist Medical Center, Des Moines, IA, USA.
Iowa Methodist Medical Center · USDrake University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Fluoroquinolone (quinolones) antibiotics are commonly prescribed worldwide. Hypersensitivity reactions to these agents have been reported, but little systematic data exists concerning prevalence, types of reactions, or associated factors. Objective To identify the prevalence of patients reporting an allergy to quinolones, types of reactions claimed, and patient information associated with allergy. Setting A tertiary 370 bed level 1 trauma center, located in a Midwestern City in the United States. Method A retrospective cohort study was conducted. Included in the study were all unique patients 18 years or older admitted to our hospital in 2016 with a length of stay ≥ 24 h. Collected data elements included types of reaction, other drug allergies claimed, and patient characteristics. As a comparator group, an equal sized random sample of patients admitted during the same period reporting penicillin allergy was identified. Main Outcome Measure prevalence and descriptors of quinolone allergy. Results There were 327 patients with a quinolone allergy and 317 patients with a penicillin allergy used as the study sample. Hospital prevalence rate for quinolone allergy was 2%. Hives, rash, and nausea/vomiting were the most common reported reactions. These patients tended to be older than penicillin allergy patients and had an association with concomitant intravenous contrast allergy. Tendonitis or tendon rupture was reported in quinolone patients. Conclusion The prevalence of patients claiming a quinolone allergy in the study hospital was 2%. Common hypersensitivity reactions were reported. Data tended to support a possible association between intravenous contrast allergy and quinolone allergy.

Indexed as

Adverse Drug Reaction Reporting SystemsInpatientsPharmacovigilanceAdultAgedAged, 80 and overAnti-Bacterial AgentsContrast MediaDrug HypersensitivityFemaleFluoroquinolonesHospital Bed Capacity, 300 to 499HumansMaleMiddle AgedMidwestern United StatesAnti-Bacterial AgentsContrast MediaFluoroquinolonesAntibiotic allergiesAntimicrobial stewardshipFluoroquinoloneHospital inpatientsPenicillinUnited States

Identifiers

PMID29542036
OpenAlexW2794058997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.